CARDIFF ONCOLOGY, INC. Gain (Loss) on Extinguishment of Debt
CARDIFF ONCOLOGY, INC. (CRDF) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2020-02-27
- CARDIFF ONCOLOGY, INC. gain (loss) on extinguishment of debt for the quarter ending 2019-12-31 was $0.00.
- CARDIFF ONCOLOGY, INC. gain (loss) on extinguishment of debt for the quarter ending 2019-09-30 was $0.00.
- CARDIFF ONCOLOGY, INC. gain (loss) on extinguishment of debt for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
- CARDIFF ONCOLOGY, INC. gain (loss) on extinguishment of debt for the quarter ending 2019-03-31 was $0.00.
- CARDIFF ONCOLOGY, INC. gain (loss) on extinguishment of debt for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- CARDIFF ONCOLOGY, INC. gain (loss) on extinguishment of debt for fiscal 2018 was $17.97K.
- CARDIFF ONCOLOGY, INC. gain (loss) on extinguishment of debt for fiscal 2017 was -$1.66M.
- CARDIFF ONCOLOGY, INC. gain (loss) on extinguishment of debt for fiscal 2016 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month | Gain (Loss) on Extinguishment of Debt 152 month | Gain (Loss) on Extinguishment of Debt 155 month | Gain (Loss) on Extinguishment of Debt 158 month | Gain (Loss) on Extinguishment of Debt 161 month | Gain (Loss) on Extinguishment of Debt 164 month | Gain (Loss) on Extinguishment of Debt 167 month | Gain (Loss) on Extinguishment of Debt 170 month | Gain (Loss) on Extinguishment of Debt 173 month | Gain (Loss) on Extinguishment of Debt 176 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $0.00 derived: sum of 3 quarters · filed 2020-02-27 | $0.00 10-K · filed 2020-02-27 | |||||||||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | $0.00 derived: sum of 4 quarters · filed 2020-02-27 | |||||||||
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | $0.00 derived: sum of 3 quarters · filed 2020-02-27 | $0.00 derived: sum of 4 quarters · filed 2020-02-27 | |||||||||
| 2019-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2020-02-27 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $0.00 derived: sum of 3 quarters · filed 2020-02-27 | $17.97K derived: sum of 4 quarters · filed 2020-02-27 | |||||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $17.97K derived: sum of 3 quarters · filed 2020-02-27 | $17.97K 10-K · filed 2020-02-27 | |||||||||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-07 | $17.97K derived: sum of 2 quarters · filed 2019-11-07 | $17.97K 10-Q · filed 2019-11-07 | ||||||||||
| 2018-06-30 | $17.97K 10-Q · filed 2019-08-08 | $17.97K 10-Q · filed 2019-08-08 | |||||||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $0.00 derived: sum of 2 quarters · filed 2019-03-06 | -$1.66M derived: sum of 3 quarters · filed 2019-03-06 | -$1.66M 10-K · filed 2019-03-06 | |||||||||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-07 | -$1.66M derived: sum of 2 quarters · filed 2018-11-07 | -$1.66M 10-Q · filed 2018-11-07 | ||||||||||
| 2017-06-30 | -$1.66M 10-Q · filed 2018-08-03 | -$1.66M 10-Q · filed 2018-08-03 | |||||||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $0.00 derived: sum of 2 quarters · filed 2018-02-26 | $0.00 derived: sum of 3 quarters · filed 2018-02-26 | $0.00 10-K · filed 2018-02-26 | |||||||||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | ||||||||||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-09 | $0.00 10-Q · filed 2017-08-09 | |||||||||||
| 2014-03-31 | $623.38K 10-Q · filed 2014-05-12 | ||||||||||||
| 2013-12-31 | $623.38K 10-K · filed 2014-03-17 | ||||||||||||
| 2013-09-30 | $623.38K 10-Q · filed 2013-11-14 | ||||||||||||
| 2013-06-30 | $623.38K 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | $623.38K 10-Q · filed 2013-05-14 | ||||||||||||
| 2012-12-31 | $623.38K 10-K · filed 2013-04-01 | ||||||||||||
| 2012-09-30 | $623.38K 10-Q · filed 2012-11-14 | ||||||||||||
| 2012-06-30 | $623.38K 10-Q · filed 2012-08-14 | ||||||||||||
| 2012-03-31 | $623.38K 10-Q · filed 2012-05-15 | ||||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $623.38K derived: sum of 2 quarters · filed 2014-03-17 | $623.38K 10-K · filed 2014-03-17 | ||||||||||
| 2011-09-30 | $623.38K 10-Q · filed 2012-11-14 | $623.38K 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |